Home > Market > Market Stats >  Glenmark Pharmaceuticals

GLENMARK PHARMACEUTICALS SUMMARY

Glenmark Pharmaceuticals is trading 2.27% lower at Rs 426.80 as compared to its last closing price. Glenmark Pharmaceuticals has been trading in the price range of 443.65 & 424.05. Glenmark Pharmaceuticals has given 2.97% in this year & 0.97% in the last 5 days.

 

Glenmark Pharmaceuticals has TTM P/E ratio 13.58 as compared to the sector P/E of 26.48. There are 17 analysts who have initiated coverage on Glenmark Pharmaceuticals. There are 2 analysts who have given it a strong buy rating & 7 analysts have given it a buy rating. 2 analysts have given the stock a sell rating.

 

The company posted a net profit of 272.58 Crores in its last quarter.

 

Listed peers of Glenmark Pharmaceuticals include J B Chemicals & Pharmaceuticals (0.1%), Sanofi India (-0.11%), Glenmark Pharmaceuticals (-2.27%) etc.

 

Glenmark Pharmaceuticals has a 46.65% promoter holding & 53.35% public holding.

FAQs about Glenmark Pharmaceuticals

Glenmark Pharmaceuticals is trading at 426.80 as on 24 Mar, 2023 3:29:50 PM. This is -2.27% lower as compared to its previous closing price of 436.7
The market capitalization of Glenmark Pharmaceuticals is 12323.69 Cr as on 24 Mar, 2023 3:29:50 PM.
The average broker rating on Glenmark Pharmaceuticals is Buy. The breakup of analyst rating is given below -
  • 0 analysts have given a strong sell rating
  • 2 analysts have given a sell rating
  • 6 analysts have given a hold rating
  • 7 analysts have given a buy rating
  • 2 analysts have given a strong buy rating
The 52 wk high for Glenmark Pharmaceuticals is 487.15 whereas the 52 wk low is 348.9
Glenmark Pharmaceuticals can be analyzed on the following key metrics -
  • TTM P/E: 13.58
  • Sector P/E: 26.48
  • Dividend Yield: 0.57%
  • D/E ratio: -
Glenmark Pharmaceuticals reported a net profit of 941.71 Cr in 2022.
Recommended For You
×
Get alerts on WhatsApp
Set Preferences My ReadsWatchlistFeedbackRedeem a Gift CardLogout